Analysts Set Schrödinger, Inc. (NASDAQ:SDGR) PT at $32.29

Schrödinger, Inc. (NASDAQ:SDGR - Get Free Report) has been given an average recommendation of "Buy" by the eight ratings firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $32.29.

A number of analysts recently commented on SDGR shares. KeyCorp boosted their target price on Schrödinger from $25.00 to $27.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Piper Sandler lowered their target price on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a report on Thursday, February 27th.

Insider Activity

In other news, CFO Geoffrey Craig Porges sold 5,491 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $21.76, for a total transaction of $119,484.16. Following the completion of the sale, the chief financial officer now owns 27,544 shares of the company's stock, valued at $599,357.44. This represents a 16.62 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 8.60% of the company's stock.

Remove Ads

Institutional Investors Weigh In On Schrödinger

Several institutional investors and hedge funds have recently modified their holdings of the stock. Rubric Capital Management LP grew its holdings in Schrödinger by 17.7% during the 3rd quarter. Rubric Capital Management LP now owns 3,685,503 shares of the company's stock valued at $68,366,000 after buying an additional 555,503 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Schrödinger by 60.2% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,510,518 shares of the company's stock valued at $67,718,000 after acquiring an additional 1,319,464 shares during the last quarter. Nikko Asset Management Americas Inc. grew its holdings in shares of Schrödinger by 108.7% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 2,464,911 shares of the company's stock valued at $47,499,000 after purchasing an additional 1,283,949 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in Schrödinger by 17.2% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,279,313 shares of the company's stock worth $43,968,000 after purchasing an additional 334,131 shares during the last quarter. Finally, State Street Corp raised its stake in Schrödinger by 1.8% during the third quarter. State Street Corp now owns 2,155,620 shares of the company's stock valued at $39,987,000 after purchasing an additional 38,972 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Schrödinger Trading Down 1.5 %

NASDAQ SDGR traded down $0.30 on Thursday, hitting $19.96. 856,997 shares of the company's stock were exchanged, compared to its average volume of 763,113. Schrödinger has a 52 week low of $16.67 and a 52 week high of $29.15. The stock has a market cap of $1.46 billion, a price-to-earnings ratio of -8.53 and a beta of 1.62. The stock has a 50-day moving average of $23.11 and a 200-day moving average of $20.79.

Schrödinger (NASDAQ:SDGR - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported ($0.55) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.20). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The business had revenue of $88.32 million for the quarter, compared to analyst estimates of $83.20 million. As a group, analysts predict that Schrödinger will post -2.37 earnings per share for the current year.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.